Publication | Closed Access

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients

Health SciencesCystic Fibrosis PatientsRespiratory InfectionInfectious Respiratory DiseaseAerosolized TherapyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceStenotrophomonas MaltophiliaDrug Resistance